|
1
|
Nasim F, Sabath BF and Eapen GA: Lung
Cancer. Med Clin North Am. 103:463–473. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The Eighth Edition AJCC Cancer Staging Manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jain D and Roy-Chowdhuri S: Molecular
Pathology of Lung Cancer Cytology Specimens: A Concise Review. Arch
Pathol Lab Med. 142:1127–1133. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhang R, Deng Y, Zhang Y, Zhai GQ, He RQ,
Hu XH, Wei DM, Feng ZB and Chen G: Upregulation of HOXA13 as a
potential tumorigenesis and progression promoter of LUSC based on
qRT-PCR and bioinformatics. Int J Clin Exp Pathol. 10:10650–10665.
2017.PubMed/NCBI
|
|
7
|
Drilon A, Rekhtman N, Ladanyi M and Paik
P: Squamous-cell carcinomas of the lung: Emerging biology,
controversies, and the promise of targeted therapy. Lancet Oncol.
13:e418–e426. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Miano JM, Krahe R, Garcia E, Elliott JM
and Olson EN: Expression, genomic structure and high resolution
mapping to 19p13.2 of the human smooth muscle cell calponin gene.
Gene. 197:215–224. 1997.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wang X, Wu K, Zhang Z, Lan M, Jin J and
Fan D: The effect of calponin and caldesmon in regulation of the
gastrointestinal motility during pathophysiological adaptation.
Zhonghua Nei Ke Za Zhi. 40:459–462. 2001.PubMed/NCBI(In Chinese).
|
|
10
|
Lv B, Zhao J, Yang F, Huang X, Chen G,
Yang K, Liu S, Fan C, Fu H and Chen Z: Phenotypic transition of
corpus cavernosum smooth muscle cells subjected to hypoxia. Cell
Tissue Res. 357:823–833. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Koganehira Y, Takeoka M, Ehara T, Sasaki
K, Murata H, Saida T and Taniguchi S: Reduced expression of
actin-binding proteins, h-caldesmon and calponin h1, in the
vascular smooth muscle inside melanoma lesions: An adverse
prognostic factor for malignant melanoma. Br J Dermatol.
148:971–980. 2003.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sasaki Y, Yamamura H, Kawakami Y, Yamada
T, Hiratsuka M, Kameyama M, Ohigashi H, Ishikawa O, Imaoka S,
Ishiguro S, et al: Expression of smooth muscle calponin in tumor
vessels of human hepatocellular carcinoma and its possible
association with prognosis. Cancer. 94:1777–1786. 2002.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yamane T, Asanoma K, Kobayashi H, Liu G,
Yagi H, Ohgami T, Ichinoe A, Sonoda K, Wake N and Kato K:
Identification of the critical site of calponin 1 for suppression
of ovarian cancer properties. Anticancer Res. 35:5993–5999.
2015.PubMed/NCBI
|
|
14
|
Martín de las Mulas J, Reymundo C,
Espinosa de los Monteros A, Millán Y and Ordás J: Calponin
expression and myoepithelial cell differentiation in canine, feline
and human mammary simple carcinomas. Vet Comp Oncol. 2:24–35.
2004.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Krishnamurthy N and Kurzrock R: Targeting
the Wnt/beta-catenin pathway in cancer: Update on effectors and
inhibitors. Cancer Treat Rev. 62:50–60. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Teng Y, Wang X, Wang Y and Ma D:
Wnt/beta-catenin signaling regulates cancer stem cells in lung
cancer A549 cells. Biochem Biophys Res Commun. 392:373–379.
2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yang S, Liu Y, Li MY, Ng CSH, Yang SL,
Wang S, Zou C, Dong Y, Du J, Long X, et al: FOXP3 promotes tumor
growth and metastasis by activating Wnt/β-catenin signaling pathway
and EMT in non-small cell lung cancer. Mol Cancer.
16(124)2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Huang Y, Liu L and Liu A: Dickkopf-1:
Current knowledge and related diseases. Life Sci. 209:249–254.
2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Katoh M: Multi-layered prevention and
treatment of chronic inflammation, organ fibrosis and cancer
associated with canonical WNT/β-catenin signaling activation
(Review). Int J Mol Med. 42:713–725. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chanvorachote P, Sriratanasak N and
Nonpanya N: C-myc Contributes to Malignancy of Lung Cancer: A
potential anticancer drug target. Anticancer Res. 40:609–618.
2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Samarghandian S, Azimi-Nezhad M and
Farkhondeh T: Thymoquinone-induced antitumor and apoptosis in human
lung adenocarcinoma cells. J Cell Physiol. 234:10421–10431.
2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Cagle PT, Allen TC and Olsen RJ: Lung
cancer biomarkers: Present status and future developments. Arch
Pathol Lab Med. 137:1191–1198. 2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Williams JP, Micoli K and McDonald JM:
Calmodulin-an often-ignored signal in osteoclasts. Ann N Y Acad
Sci. 1192:358–364. 2010.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Menéndez JA, Mehmi I, Griggs DW and Lupu
R: The angiogenic factor CYR61 in breast cancer: Molecular
pathology and therapeutic perspectives. Endocr Relat Cancer.
10:141–152. 2003.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Jackson MT, Moradi B, Smith MM, Jackson CJ
and Little CB: Activation of matrix metalloproteinases 2, 9, and 13
by activated protein C in human osteoarthritic cartilage
chondrocytes. Arthritis Rheumatol. 66:1525–1536. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Milner JM, Rowan AD, Cawston TE and Young
DA: Metalloproteinase and inhibitor expression profiling of
resorbing cartilage reveals pro-collagenase activation as a
critical step for collagenolysis. Arthritis Res Ther.
8(R142)2006.PubMed/NCBI View
Article : Google Scholar
|
|
29
|
Lee HM, Hwang KA and Choi KC: Diverse
pathways of epithelial mesenchymal transition related with cancer
progression and metastasis and potential effects of endocrine
disrupting chemicals on epithelial mesenchymal transition process.
Mol Cell Endocrinol. 457:103–113. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hao Y, Baker D and Ten Dijke P:
TGF-β-mediated epithelial-mesenchymal transition and cancer
metastasis. Int J Mol Sci. 20(2767)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Luo T, Yan A, Liu L, Jiang H, Feng C, Liu
G, Liu F, Tang D and Zhou T: In vitro study of joint intervention
of E-cad and Bmi-1 mediated by transcription activator-like
effector nuclease in nasopharyngeal carcinoma. Zhong Nan Da Xue Xue
Bao Yi Xue Ban. 43:229–239. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
32
|
Liu Y, Yang F, Liang S, Liu Q, Fu S, Wang
Z, Yang C and Lin J: N-Cadherin Upregulation Promotes the
Neurogenic Differentiation of Menstrual Blood-Derived Endometrial
Stem Cells. Stem Cells Int. 2018(3250379)2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Igbinigie E, Guo F, Jiang SW, Kelley C and
Li J: Dkk1 involvement and its potential as a biomarker in
pancreatic ductal adenocarcinoma. Clin Chim Acta. 488:226–234.
2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Jaschke N, Hofbauer LC, Göbel A and
Rachner TD: Evolving functions of Dickkopf-1 in cancer and
immunity. Cancer Lett. 482:1–7. 2020.PubMed/NCBI View Article : Google Scholar
|
